Paper39684376
The Role of Medium Polarity in the Efficiency of Albumin Binding with Hydrophobic Ligands: Experimental Studies and a Molecular Dynamics Investigation.
Zazeri G and 4 others. Int J Mol Sci, 2024. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. The Role of Medium Polarity in the Efficiency of Albumin Binding with Hydrophobic Ligands: Experimental Studies and a Molecular Dynamics Investigation. Papers, record 39684376. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39684376
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Role of Medium Polarity in the Efficiency of Albumin Binding with Hydrophobic Ligands: Experimental Studies and a Molecular Dynamics Investigation.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Molecular Dynamics Simulation | Major topic |
| Hydrophobic and Hydrophilic Interactions | Major topic |
| Protein Binding | Major topic |
| Ligands | |
| Humans | |
| Serum Albumin, Human | |
| Rutin | |
| Quercetin | |
| Dioxanes | |
| Binding Sites |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CNPq, N°: 302121/2022-6 and 422893/2021-8 | National Council for Scientific and Technological Development | PubMed | ||
| 465637/2014-0 | National Institute of Science and Technology - INCT BioNat | PubMed | ||
| FAPESP, N°: 2024/00959-0 | State of Sao Paulo Research Foundation | PubMed | ||
| NCC/GridUNESP | Center for Scientific Computing | PubMed |
Source PubMed
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34576249 | Serum Albumin: A Multifaced Enzyme. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34576249 | PubMed |
| 2 | 35853255 | Structural aspects of formetanate hydrochloride binding with human serum albumin using spectroscopic and molecular modeling techniques. | Spectrochim Acta A Mol Biomol Spectrosc | 2022 | https://conductscience.org/library/papers/35853255 | PubMed |
| 3 | 31199906 | Behavior of the DPH fluorescence probe in membranes perturbed by drugs. | Chem Phys Lipids | 2019 | https://conductscience.org/library/papers/31199906 | PubMed |
| 4 | 4052559 | Membrane structural domains. Resolution limits using diphenylhexatriene fluorescence decay. | Biophys J | 1985 | https://conductscience.org/library/papers/4052559 | PubMed |
| 5 | 34217110 | Dietary polyphenols inhibit plasma protein arabinosylation: Biomolecular interaction of genistein and ellagic acid with serum albumins. | Biophys Chem | 2021 | https://conductscience.org/library/papers/34217110 | PubMed |
| 6 | 17125196 | A novel method to simulate the hydrophobic effect and its application to the ranking of host/guest complexes. | J Chem Inf Model | 2006 | https://conductscience.org/library/papers/17125196 | PubMed |
| 7 | 38574292 | Role for Carboxylic Acid Moiety in NSAIDs: Favoring the Binding at Site II of Bovine Serum Albumin. | Mol Pharm | 2024 | https://conductscience.org/library/papers/38574292 | PubMed |
| 8 | 36296602 | The Hydrophobic Effects: Our Current Understanding. | Molecules | 2022 | https://conductscience.org/library/papers/36296602 | PubMed |
| 9 | 15051358 | Fluorescence quenching methods to study protein-nucleic acid interactions. | Methods Enzymol | 2004 | https://conductscience.org/library/papers/15051358 | PubMed |
| 10 | 35868967 | Elucidating the binding and inhibitory potential of p-coumaric acid against amyloid fibrillation and their cytotoxicity: Biophysical and docking analysis. | Biophys Chem | 2022 | https://conductscience.org/library/papers/35868967 | PubMed |
| 11 | 26821017 | Insights into Protein-Ligand Interactions: Mechanisms, Models, and Methods. | Int J Mol Sci | 2016 | https://conductscience.org/library/papers/26821017 | PubMed |
| 12 | 16211538 | GROMACS: fast, flexible, and free. | J Comput Chem | 2005 | https://conductscience.org/library/papers/16211538 | PubMed |
| 13 | 31710813 | Strong Adverse Contribution of Conformational Dynamics to Streptavidin-Biotin Binding. | J Phys Chem B | 2020 | https://conductscience.org/library/papers/31710813 | PubMed |
| 14 | 35514705 | Methyl divanillate: redox properties and binding affinity with albumin of an antioxidant and potential NADPH oxidase inhibitor. | RSC Adv | 2019 | https://conductscience.org/library/papers/35514705 | PubMed |
| 15 | 26598349 | An Automated Force Field Topology Builder (ATB) and Repository: Version 1.0. | J Chem Theory Comput | 2011 | https://conductscience.org/library/papers/26598349 | PubMed |
| 16 | 27765226 | Octyl gallate: An antioxidant demonstrating selective and sensitive fluorescent property. | Food Chem | 2017 | https://conductscience.org/library/papers/27765226 | PubMed |
| 17 | 8744570 | VMD: visual molecular dynamics. | J Mol Graph | 1996 | https://conductscience.org/library/papers/8744570 | PubMed |
| 18 | 32115798 | Entropy-driven binding of octyl gallate in albumin: Failure in the application of temperature effect to distinguish dynamic and static fluorescence quenching. | J Mol Recognit | 2020 | https://conductscience.org/library/papers/32115798 | PubMed |
| 19 | 27796417 | Enthalpy-entropy compensation: the role of solvation. | Eur Biophys J | 2017 | https://conductscience.org/library/papers/27796417 | PubMed |
| 20 | 24146932 | Investigation of human albumin-induced circular dichroism in dansylglycine. | PLoS One | 2013 | https://conductscience.org/library/papers/24146932 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42923525 | Comparative Evaluation of the Antitumor Effect of Rosmarinic Acid and Nordihydroguaiaretic Acid in Osteosarcoma Cells. | ACS Omega | 2026 | https://conductscience.org/library/papers/42923525 | PubMed |
| 42762338 | Computational Modeling and MM-PBSA-Based Molecular Dynamics Investigation of Unexplored tRNA Isoleucine Lysidine Synthetase from Mycobacterium tuberculosis with Hyperbranched Amoxicilloyl-Poly-L-Lysine. | J Mol Model | 2026 | https://conductscience.org/library/papers/42762338 | PubMed |
| 41148665 | Insight into the Roles of Albumin-Alone and in Combination with Either Voriconazole or Antimicrobial Peptides Derived from Chromogranin A-In the Growth of Different Microbial Species. | Antibiotics (Basel) | 2025 | https://conductscience.org/library/papers/41148665 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39684376
GET https://conductscience.org/api/papers/v1/39684376/references?page=2